Drug intelligence / Profile preview

GIRLRG peptide

Development stage
Preclinical
Lead developer
Vanderbilt University
Modality
Peptides
Administration
Intravenous
01

Overview

GIRLRG peptide is a synthetic hexapeptide (Gly-Ile-Arg-Leu-Arg-Gly) discovered via in vivo phage-display biopanning that specifically targets the 78 kDa glucose-regulated protein (GRP78), an endoplasmic reticulum stress chaperone overexpressed on the cell surface of various irradiated cancer cells and tumor-associated microvascular endothelial cells. GIRLRG binds to the ATPase domain of GRP78. It has been developed as a targeting ligand for cancer-specific drug delivery and noninvasive tumor imaging. When conjugated to polyethylene glycol (PEG) and radiolabeled with Indium-111 (111In-PEG-GIRLRG), it serves as a diagnostic imaging agent for single-photon emission computed tomography (SPECT) to detect tumors such as glioma, lung, pancreatic, esophageal, and cervical cancers. It has also been utilized to retarget adenoviruses for radiation-guided gene delivery and to target paclitaxel-encapsulated nanoparticles to tumors.

Other names
111In-PEG-GIRLRGGIRLRGGly-Ile-Arg-Leu-Arg-GlyPEG-GIRLRG
02

Targets

HSPA5 (Heat shock protein family A member 5)

Beyond the preview

Go deeper on GIRLRG peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GIRLRG peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call